US drug firms under fire for trials in Chinese-occupied East Turkestan
US lawmakers are sounding the alarm about American drug companies conducting clinical trials in China’s occupied Eastern Turkistan, which is also known as Xinjiang.
The United States already has declared China is committing genocide against the Uyghur population in the region.
In a letter addressed to the Food and Drug Administration or FDA, Representatives John Moolenaar and Raja Krishnamoorthi demanded answers on the ethics and oversight of these trials.
They say Uyghurs may be being forced into participating in medical procedures.
The representatives also questioned whether these trials could be inadvertently supporting genocide and if American firms are benefiting from unethical practices.
The FDA has yet to comment on these claims but did acknowledge receipt of the letter.
The controversy adds to the growing scrutiny of American companies who may be supporting forced labor and human rights abuses linked to China’s repression of Uyghurs.
Experts say it underscores the need for transparency and ethical standards in international medical research.
Have Your Say!
Have you been affected by the issues raised in this story? Please share your experiences by emailing haveyoursay@soundvision.com.
Please include a contact number if you are willing to speak to a Muslim Network TV’s representative. You can also get in touch in the following ways:
Tweet: @MuslimNetworkTV
We must take charge of our narrative. Research indicates that 92% of their Muslim coverage is negative. Help us change that.
